Strides Pharma Science today announced its partnership with Medicines Patent Pool MPP to commercialize molnupiravir in the international markets Strides and its subsidiary Universal Corporation Kenya have entered into a voluntary non]exclusive sub]license partnership with MPP covering 105 countries as part of MSD NYSE MRK a trading name of Merck Co Inc Kenilworth NJ USA and MPPfs partnership to enable a global reach for molnupiravir Strides and UCL will manufacture the product at their WHO PQ facilities in India and Nairobi Kenya UCL owns and operates one of the two WHO PQ facilities in the Sub]Saharan region In December 2021 Strides received Emergency Use Authorization EUA from the DCGI to launch molnupiravir 200mg in India under the brand name StripiravirTM Besides the 200mg strength Strides has also developed and manufactured molnupiravir in 400mg which significantly benefits the patients by reducing the pill burden and ensuring better compliance
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.